ING Group’s Labcorp LH Stock Holding History

ING Group’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-969	Closed	-$243K	–	571
2025 Q4	$243K	Buy	+969	New	+$257K	﹤0.01%	541
2025 Q1	–	Sell	-10,682	Closed	-$2.45M	–	551
2024 Q4	$2.45M	Sell	10,682 -547	-5%	-$125K	0.02%	380
2024 Q3	$2.51M	Sell	11,229 -114	-1%	-$25.1K	0.01%	392
2024 Q2	$2.31M	Sell	11,343 -291	-3%	-$59.2K	0.01%	415
2024 Q1	$2.54M	Sell	11,634 -29,989	-72%	-$6.61M	0.02%	414
2023 Q4	$9.46M	Buy	41,623 +31,817	+324%	+$6.68M	0.08%	218
2023 Q3	$1.97M	Buy	9,806 +6,733	+219%	+$1.42M	0.02%	378
2023 Q2	$637K	Sell	3,073 -20,252	-87%	-$3.93M	﹤0.01%	454
2023 Q1	$4.6M	Buy	23,325 +5,791	+33%	+$1.19M	0.04%	260
2022 Q4	$3.55M	Buy	+17,534	New	+$3.43M	0.04%	278
2022 Q3	–	Sell	-20,305	Closed	-$4.09M	–	482
2022 Q2	$4.09M	Buy	20,305 +3,112	+18%	+$663K	0.05%	278
2022 Q1	$3.9M	Buy	17,193 +2,653	+18%	+$624K	0.04%	284
2021 Q4	$3.92M	Buy	14,540 +5,091	+54%	+$1.26M	0.04%	327
2021 Q3	$2.29M	Buy	9,449 +115	+1%	+$29K	0.03%	332
2021 Q2	$2.21M	Buy	9,334 +1,812	+24%	+$413K	0.04%	293
2021 Q1	$1.65M	Buy	7,522 +3	+0%	+$602	0.03%	285
2020 Q4	$1.31M	Buy	7,519 +5,009	+200%	+$865K	0.03%	322
2020 Q3	$406K	Buy	+2,510	New	+$398K	0.02%	334
2020 Q2	–	Sell	-2,073	Closed	-$225K	–	361
2020 Q1	$225K	Sell	2,073 -5,679	-73%	-$818K	0.01%	346
2019 Q4	$1.13M	Buy	7,752 +655	+9%	+$94.6K	0.03%	283
2019 Q3	$1.02M	Sell	7,097 -2,601	-27%	-$380K	0.03%	296
2019 Q2	$1.44M	Sell	9,698 -62	-0.6%	-$8.65K	0.03%	318
2019 Q1	$1.28M	Sell	9,760 -10,650	-52%	-$1.31M	0.03%	277
2018 Q4	$2.22M	Sell	20,410 -598	-3%	-$80.1K	0.05%	214
2018 Q3	$3.13M	Buy	21,008 +8,259	+65%	+$1.26M	0.05%	211
2018 Q2	$1.97M	Buy	12,749 +631	+5%	+$95.3K	0.04%	219
2018 Q1	$1.68M	Buy	+12,118	New	+$1.78M	0.03%	234
2017 Q4	–	Sell	-12,861	Closed	-$1.67M	–	837
2017 Q3	$1.67M	Buy	12,861 +3,696	+40%	+$493K	0.03%	247
2017 Q2	$1.21M	Sell	9,165 -12	-0.1%	-$1.47K	0.02%	285
2017 Q1	$1.13M	Sell	9,177 -803	-8%	-$95.1K	0.02%	320
2016 Q4	$1.1M	Sell	9,980 -70,859	-88%	-$7.87M	0.02%	303
2016 Q3	$9.41M	Sell	80,839 -58,770	-42%	-$6.93M	0.11%	112
2016 Q2	$15.6M	Buy	139,609 +136,871	+4,999%	+$14.7M	0.21%	61
2016 Q1	$276K	Buy	+2,738	New	+$263K	﹤0.01%	467
2015 Q4	–	Sell	-93,856	Closed	-$8.74M	–	665
2015 Q3	$8.74M	Sell	93,856 -80,749	-46%	-$8.35M	0.06%	220
2015 Q2	$18.2M	Buy	174,605 +169,961	+3,660%	+$17.7M	0.1%	179
2015 Q1	$503K	Buy	4,644 +733	+19%	+$75.4K	﹤0.01%	683
2014 Q4	$363K	Buy	+3,911	New	+$345K	﹤0.01%	704

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ING Group's LH Position: Q1 2026 in Review

ING Group sold out of Labcorp (LH) in Q1 2026, closing a stake of 969 shares — an estimated $243K sold.

ING Group first reported a position in LH in Q4 2014 and held it in 38 quarters. The position peaked at $18.2M in Q2 2015. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

ING Group reported no remaining Labcorp position as of Q1 2026 after selling out during the quarter.
ING Group sold 969 Labcorp shares in Q1 2026, an estimated $243K.
ING Group first reported a position in Labcorp in Q4 2014 and held it in 38 quarters.
ING Group's Labcorp position peaked at $18.2M in Q2 2015.
1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on ING Group's 13F filing for Q1 2026, filed 11 May 2026.